311 related articles for article (PubMed ID: 11381263)
1. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.
Rudolph KL; Millard M; Bosenberg MW; DePinho RA
Nat Genet; 2001 Jun; 28(2):155-9. PubMed ID: 11381263
[TBL] [Abstract][Full Text] [Related]
2. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Farazi PA; Glickman J; Horner J; Depinho RA
Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
Farazi PA; Glickman J; Jiang S; Yu A; Rudolph KL; DePinho RA
Cancer Res; 2003 Aug; 63(16):5021-7. PubMed ID: 12941829
[TBL] [Abstract][Full Text] [Related]
4. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
Watson SA; Smith AM
Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
[TBL] [Abstract][Full Text] [Related]
5. Telomere dysfunction: multiple paths to the same end.
Harrington L; Robinson MO
Oncogene; 2002 Jan; 21(4):592-7. PubMed ID: 11850784
[TBL] [Abstract][Full Text] [Related]
6. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
de Souza Nascimento P; Alves G; Fiedler W
Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
[TBL] [Abstract][Full Text] [Related]
9. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solórzano CO; Lockett S; DePinho RA; Gray J; Hanahan D
Cancer Cell; 2004 Oct; 6(4):373-85. PubMed ID: 15488760
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
11. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma.
Gordon KE; Ireland H; Roberts M; Steeghs K; McCaul JA; MacDonald DG; Parkinson EK
Cancer Res; 2003 Jan; 63(2):458-67. PubMed ID: 12543803
[TBL] [Abstract][Full Text] [Related]
12. Telomeres and telomerase in cancer stem cells.
Ju Z; Rudolph KL
Eur J Cancer; 2006 Jun; 42(9):1197-203. PubMed ID: 16644207
[TBL] [Abstract][Full Text] [Related]
13. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
Jaskelioff M; Song W; Xia J; Liu C; Kramer J; Koido S; Gendler SJ; Calderwood SK; Gong J
Oncogene; 2009 Dec; 28(48):4225-36. PubMed ID: 19734944
[TBL] [Abstract][Full Text] [Related]
14. [Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach].
Maruyama Y; Hanai H; Kaneko E
Nihon Rinsho; 1998 May; 56(5):1186-9. PubMed ID: 9613119
[TBL] [Abstract][Full Text] [Related]
15. Telomeres and telomerase: a dual role in hepatocarcinogenesis.
Satyanarayana A; Manns MP; Rudolph KL
Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430
[TBL] [Abstract][Full Text] [Related]
16. Regulation of telomerase and its hTERT messenger in colorectal cancer.
Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
[TBL] [Abstract][Full Text] [Related]
17. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
[TBL] [Abstract][Full Text] [Related]
18. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment.
Ju Z; Jiang H; Jaworski M; Rathinam C; Gompf A; Klein C; Trumpp A; Rudolph KL
Nat Med; 2007 Jun; 13(6):742-7. PubMed ID: 17486088
[TBL] [Abstract][Full Text] [Related]
19. Radiation and chemotherapy bystander effects induce early genomic instability events: telomere shortening and bridge formation coupled with mitochondrial dysfunction.
Gorman S; Tosetto M; Lyng F; Howe O; Sheahan K; O'Donoghue D; Hyland J; Mulcahy H; O'Sullivan J
Mutat Res; 2009 Oct; 669(1-2):131-8. PubMed ID: 19540247
[TBL] [Abstract][Full Text] [Related]
20. Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele.
Cormier RT; Dove WF
Cancer Res; 2000 Jul; 60(14):3965-70. PubMed ID: 10919675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
